Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/SyndromesdRecommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

被引：1

作者：

Aakash, Fnu ^{[1
,2
]}

Gisriel, Savanah D. ^{[3
,4
]}

Zeidan, Amer M. ^{[5
]}

Bennett, John M. ^{[6
]}

Bejar, Rafael ^{[7
]}

Bewersdorf, Jan Philipp ^{[8
]}

Borate, Uma M. ^{[9
]}

Boultwood, Jacqueline ^{[10
]}

Brunner, Andrew M. ^{[11
]}

Buckstein, Rena ^{[12
]}

Carraway, Hetty E. ^{[13
]}

Churpek, Jane E. ^{[14
]}

Daver, Naval G. ^{[15
]}

Dezern, Amy E. ^{[16
]}

Efficace, Fabio ^{[17
]}

Fenaux, Pierre ^{[18
]}

Figueroa, Maria E. ^{[19
]}

Garcia-Manero, Guillermo ^{[15
]}

Gore, Steven D. ^{[20
]}

Greenberg, Peter L. ^{[21
]}

Griffiths, Elizabeth A. ^{[22
]}

Halene, Stephanie ^{[5
]}

Hourigan, Christopher S. ^{[23
]}

Kim, Tae Kon ^{[24
]}

Kim, Nina ^{[25
]}

Komrokji, Rami S. ^{[26
]}

Kutchroo, Vijay K. ^{[27
]}

List, Alan F. ^{[28
]}

Little, Richard F. ^{[20
]}

Majeti, Ravindra ^{[21
]}

Nazha, Aziz ^{[29
]}

Nimer, Stephen D. ^{[30
]}

Odenike, Olatoyosi ^{[31
,32
]}

Padron, Eric ^{[26
]}

Patnaik, Mrinal M. ^{[33
]}

Platzbecker, Uwe ^{[34
]}

Porta, Matteo G. Della ^{[35
]}

Roboz, Gail J. ^{[36
,37
]}

Sallman, David A. ^{[26
]}

Santini, Valeria ^{[38
]}

Sanz, Guillermo ^{[39
,40
,41
]}

Savona, Michael R. ^{[24
]}

Sekeres, Mikkael A. ^{[30
]}

Stahl, Maximilian ^{[42
]}

Starczynowski, Daniel T. ^{[43
]}

Steensma, David P. ^{[44
]}

Taylor, Justin ^{[30
]}

Abdel-Wahab, Omar ^{[8
]}

Wei, Andrew H. ^{[45
]}

Xie, Zhuoer ^{[26
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[2] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA

[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT USA

[4] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA

[5] Yale Sch Med, Yale Canc Ctr, Dept Internal Med, Sect Hematol,Sch Med, New Haven, CT USA

[6] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Div Hematopathol, Rochester, NY USA

[7] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, La Jolla, CA USA

[8] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY USA

[9] Ohio State Univ, Div Hematol, Comprehens Canc Ctr, Columbus, OH USA

[10] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England

[11] Brigham & Womens Hosp, Div Hematol, Boston, MA USA

[12] Sunnybrook Hlth Sci Ctr, Dept Med, Div Med Oncol Hematol, Toronto, ON, Canada

[13] Cleveland Clin, Leukemia Program, Taussig Canc Inst, Hematol & Med Oncol, Cleveland, OH USA

[14] Univ Wisconsin Madison, Carbone Canc Ctr, Div Haematol Oncol & Palliat Care, Madison, WI 53706 USA

[15] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[16] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[17] Italian Grp Adult Hematol Dis GIMEMA, Hlth Outcomes Res Unit, Rome, Italy

[18] Univ Paris Cite, Serv Hematol, Paris, France

[19] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA

[20] NCI, Canc Therapy Evaluat Program, Rockville, MD USA

[21] Stanford Univ, Stanford Canc Inst, Sch Med, Dept Med,Div Hematol, Stanford, CA USA

[22] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[23] Virginia Tech, Fralin Biomed Res Inst, FBRI Canc Res Ctr, Washington, DC USA

[24] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA

[25] NCI, NIH, Bethesda, MD USA

[26] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Program, Tampa, FL USA

[27] Brigham & Womens Hosp, Boston, MA USA

[28] New York Infirm, New York, NY USA

[29] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA

[30] Univ Miami, Dept Med, Div Hematol, Div Hematol,Miller Sch Med, Miami, FL USA

[31] Univ Chicago, Sect Hematol Oncol, Leukemia Program, Chicago, IL 60637 USA

[32] Univ Chicago, Comprehens Canc Ctr, Chicago, IL USA

[33] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA

[34] Univ Hosp Leipzig, Dept Hematol & Cellular Therapy, Leipzig, Germany

[35] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[36] New York Acad Med, New York, NY USA

[37] New York Presbyterian Hosp, New York, NY USA

[38] Univ Florence, Dept Expt & Clin Med, Myelodysplast Syndromes Unit, Hematol,Azienda Osped Univ Careggi, Florence, Italy

[39] Hlth Res Inst La Fe, Valencia, Spain

[40] Hosp Univ & Politecn La Fe, Valencia, Spain

[41] ISCarlosIII, CIBERONC, Madrid, Spain

[42] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Div Leukemia, Boston, MA USA

[43] Cincinnati Childrens Hosp, Div Expt Hematol & Canc Biol, Cincinnati, OH USA

[44] David Steensma LLC, Cambridge, MA USA

[45] Royal Melbourne Hosp, Dept Haematol Lab, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia

[46] Massachusetts Gen Hosp Brigham, Dept Pathol, Boston, MA USA

来源：

MODERN PATHOLOGY | 2024年 / 37卷 / 12期

关键词：

icMDS; MDS; myelodysplastic neoplasms; myelodysplastic syndromes; classification; diagnosis; HEALTH-ORGANIZATION CLASSIFICATION; FLOW-CYTOMETRY; COPPER DEFICIENCY; 5TH EDITION; MUTATIONS; VALIDATION; RISK; ABNORMALITIES; EVOLUTION; LEUKEMIA;

D O I：

10.1016/j.modpat.2024.100615

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Myelodysplastic neoplasms/syndromes (MDS) are a heterogeneous group of biologically distinct entities characterized by variable degrees of ineffective hematopoiesis. Recently, 2 classification systems (the 5th edition of the World Health Organization Classification of Haematolymphoid tTumours and the International Consensus Classification) further subcharacterized MDS into morphologically and genetically defined groups. Accurate diagnosis and subclassification of MDS require a multistep systemic approach. The International Consortium for MDS (icMDS) summarizes a contemporary, practical, and multimodal approach to MDS diagnosis and classification. (c) 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

引用

页数：13

共 50 条

[21] Time toxicity for patients receiving oral versus parenteral hypomethylating agents for myelodysplastic syndromes/neoplasms (MDS).
Epstein, Robert S.
Zeidan, Amer Methqal
Olopoenia, Abisola
Costantino, Halley
Modi, Kushal
Salimi, Tehseen
Washington, Terri
Krenitsky, Joann
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[22] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Bacher, Ulrike
Schnittger, Susanne
Kern, Wolfgang
Weiss, Tamara
Haferlach, Torsten
Haferlach, Claudia
ANNALS OF HEMATOLOGY, 2009, 88 (12) : 1207 - 1213
[23] Deregulation of promoter methylation of the polo-like kinases in myelodysplastic syndromes (MDS) and other blood neoplasms
Ward, Alejandra
Sivakumar, Gayathri
Hamm, Caroline
Kanjeekal, Sindu
Hudson, John W.
CANCER RESEARCH, 2012, 72
[24] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Ulrike Bacher
Susanne Schnittger
Wolfgang Kern
Tamara Weiss
Torsten Haferlach
Claudia Haferlach
Annals of Hematology, 2009, 88 : 1207 - 1213
[25] Characterization of Clinical, Molecular, and Prognostic Features of the WHO 2022 Classification System for Myelodysplastic Neoplasms (MDS)
Khanna, Vishesh
Lu, Rong
Kumar, Jyoti
Stehr, Henning
Spinner, Michael A.
Silva, Oscar
Fernandez-Pol, Sebastian
Oak, Jean S.
Tan, Brent
Greenberg, Peter L.
BLOOD, 2022, 140 : 6955 - 6957
[26] Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS
Wang, Wei
Khoury, Joseph D.
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (01) : 12 - 14
[27] Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms
Xie, Zhuoer
Chen, Evan C. C.
Mendez, Lourdes M.
Komrokji, Rami
Zeidan, Amer M.
CANCER JOURNAL, 2023, 29 (03): : 130 - 137
[28] Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS
Leitch, Heather A.
Buckstein, Rena
Zhu, Nancy
Nevill, Thomas J.
Yee, Karen W. L.
Leber, Brian
Keating, Mary-Margaret
St Hilaire, Eve
Kumar, Rajat
Delage, Robert
Geddes, Michelle
Storring, John M.
Shamy, April
Elemary, Mohamed
Wells, Richard A.
LEUKEMIA RESEARCH, 2018, 74 : 21 - 41
[29] An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Mughal, Tariq I.
Cross, Nicholas C. P.
Padron, Eric
Tiu, Ramon V.
Savona, Michael
Malcovati, Luca
Tibes, Raoul
Komrokji, Rami S.
Kiladjian, Jean-Jacques
Garcia-Manero, Guillermo
Orazi, Attilio
Mesa, Ruben
Maciejewski, Jaroslaw P.
Fenaux, Pierre
Itazykson, Raphael
Mufti, Ghulam
Solary, Eric
List, Alan F.
HAEMATOLOGICA, 2015, 100 (09) : 1117 - 1130
[30] Myelodysplastic Syndromes/Neoplasms-Insights Into Pathogenesis Leading to Improved Classification, Risk Stratification, and Treatments
Rose, Michal G.
Zeidan, Amer M.
CANCER JOURNAL, 2023, 29 (03): : 109 - 110

← 1 2 3 4 5 →